Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nootropics: Reviews Reveal Undeniable Results on Neuro Laboratories’ Brain Enhancement Pill
  • USA - English


News provided by

Brain Pill Reviews

Jun 29, 2014, 11:00 ET

Share this article

Share toX

Share this article

Share toX

Is Intelligence The New Sexy?
Is Intelligence The New Sexy?

New York, NY (PRWEB) June 29, 2014 -- There’s very few people who haven’t seen, or at least heard of Bradley Cooper’s 2011 box office hit, Limitless – a movie featuring a little clear pill that allowed the use of 100% of the brain. This year, an upcoming movie Lucy hopes to up the stakes even further with a drug that allows the brain telekinetic powers and the ability to slow down time. What most people don’t know is, that while we might still be a long way off from the Limitless pill, there are supplements available out there claiming to enhance the way your brain functions.

"...while at the moment, brain enhancement might simply be a novelty, a decade from now, it might just become necessity.”

Post this

This is what Martin Brison and his team of enthusiasts do on a regular basis at Brain Pill Reviews, a non-profit organization set out with one purpose: finding the best available brain enhancing supplements, better known as nootropics, to optimize the overall performance we get from our brains, and according to Editor Brison, they just might have found it.

The Brain Pill Reviews team have reviewed and tested countless different nootropics from many different pharmaceutical companies, and while doing so have noticed a growing trend – the increasing effectiveness of supplements that positively affect the many key cognitive processes within the brain. Brison said “Brain pills are at the epitome of their advancement, and it seems as if pharmaceutical supplement companies have become the first to crack the code.”

Brain enhancement isn't new, though. The use of nootropics began as early as 1964, when piracetam was first discovered to improve memory. However, since its first use, modern neuroscience and technology has allowed more possibilities than we could even dream of. Ginkgo Biloba itself, a plant extract used to enhance memory, has been one of America’s top selling supplements for a long time. For half a decade, our newfound understanding of the brain has ushered forth the development of modern brain enhancers and nootropics that far surpass what was available many years ago.

One such modern nootropic that Brison mentioned was the critically acclaimed NITROvit from Neuro Laboratories. NITROvit, dubbed as the Advanced Cognitive Nootropic, has received a particularly positive reception on Brain Pill Reviews, as well as on many other review sites out there, nootropic forums, and, most importantly, through user feedback and testimonials. According to Editor Brison, it may very well be the closest we can get to the Limitless Pill at the moment, and will possibly hold on to that title for years to come.

NITROvit – the pride and joy behind Neuro Laboratories’ success – was purportedly created as the solution to a demand for increased mental performance. Neuro Laboratories’ push forward for innovation in neurological research and modern medicine has been remarkable in the past few years, which has allowed them to produce a nootropic supplement that can optimize focus, clarity, and learning capabilities – while also limiting the effects of Attention Deficit Disorder (ADD/ADHD). Neuro Laboratories’ website characterizes ADD/ADHD as difficulty paying attention, maintaining focus on tasks, and controlling impulsive behaviors.

In a marketplace that is incredibly saturated, it seems as if an up-and-coming product will have difficulties competing, but Editor Martin Brison sheds light on why they’ve given it their Editor’s Choice as one of the very best nootropics. “In an industry where there are new brain pills popping out of nowhere almost every other day, our jobs as reviewers require us to remain objective and focused on the results. When compared to the many other brain enhancers that we’ve reviewed, we’ve observed that what makes NITROvit so effective rests within its formula – each ingredient has been specifically selected to complement each other’s effects, and at the right doses. Also, since there is no filler present (multivitamins, caffeine, and other proprietary ingredients), there is nothing that may take away from its overall brain enhancement potential – the result is a very potent nootropic. Consider it proper nutrition for the brain, optimizing it for increased memory, focus, concentration, and motivation.”

When asked to comment on the use of brain enhancement in a professional setting, Brison explained, “While there are still some people wary of the use of these “smart drugs”, we have to admit that with the current state of the global workforce market, there is a growing demand for individuals who can perform at their very best. We’re seeing this every day with the growing competitiveness in work and academic environments. Everyone just wants to be that much better. And while at the moment, brain enhancement might simply be a novelty, a decade from now, it might just become necessity.”

Check out NITROvit and Neuro Laboratories’ upcoming products, and their solution to Brain Enhancement.

Those interested in reading Brison’s full review on NITROvit, as well as countless other reviewed brain enhancers and nootropics may visit their official website, Brain Pill Reviews.

Martin Brison, Brain Pill Reviews, +1 (914) 587-7771, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.